Search by Drug Name or NDC

    NDC 00781-2855-60 Ranitidine Hydrochloride 150 mg/1 Details

    Ranitidine Hydrochloride 150 mg/1

    Ranitidine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is RANITIDINE HYDROCHLORIDE.

    Product Information

    NDC 00781-2855
    Product ID 0781-2855_ed4bcd49-22fa-4c8d-834a-4b6085889b4b
    Associated GPIs 49200020100105
    GCN Sequence Number 016223
    GCN Sequence Number Description ranitidine HCl CAPSULE 150 MG ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 19551
    HICL Sequence Number 004520
    HICL Sequence Number Description RANITIDINE HCL
    Brand/Generic Generic
    Proprietary Name Ranitidine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranitidine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name RANITIDINE HYDROCHLORIDE
    Labeler Name Sandoz Inc
    Pharmaceutical Class Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074655
    Listing Certified Through 2024-12-31

    Package

    NDC 00781-2855-60 (00781285560)

    NDC Package Code 0781-2855-60
    Billing NDC 00781285560
    Package 60 CAPSULE in 1 BOTTLE (0781-2855-60)
    Marketing Start Date 1997-10-22
    NDC Exclude Flag N
    Pricing Information N/A